De Leeuw IH - Search Results

1

The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects.

Van Gaal LF, Vertommen J, De Leeuw IH. Van Gaal LF, et al. Among authors: de leeuw ih. Atherosclerosis. 1998 Apr;137 Suppl:S39-44. doi: 10.1016/s0021-9150(97)00316-x. Atherosclerosis. 1998. PMID: 9694540

2

Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin.

Manuel-Y-Keenoy B, Vinckx M, Vertommen J, Van Gaal L, De Leeuw I. Manuel-Y-Keenoy B, et al. Atherosclerosis. 2004 Aug;175(2):369-76. doi: 10.1016/j.atherosclerosis.2004.04.005. Atherosclerosis. 2004. PMID: 15262194 Clinical Trial.

3

Human obesity: from lipid abnormalities to lipid oxidation.

Van Gaal LF, Zhang A, Steijaert MM, De Leeuw IH. Van Gaal LF, et al. Among authors: de leeuw ih. Int J Obes Relat Metab Disord. 1995 Sep;19 Suppl 3:S21-6. Int J Obes Relat Metab Disord. 1995. PMID: 8581073 Review.

4

The beneficial effects of modest weight loss on cardiovascular risk factors.

Van Gaal LF, Wauters MA, De Leeuw IH. Van Gaal LF, et al. Among authors: de leeuw ih. Int J Obes Relat Metab Disord. 1997 Mar;21 Suppl 1:S5-9. Int J Obes Relat Metab Disord. 1997. PMID: 9130034 Review.

5

A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper-catalyzed oxidation.

Zhang A, Vertommen J, Van Gaal L, De Leeuw I. Zhang A, et al. Clin Chim Acta. 1994 Jun;227(1-2):159-73. doi: 10.1016/0009-8981(94)90144-9. Clin Chim Acta. 1994. PMID: 7955412

6

Effects of pravastatin on lipid levels, in vitro oxidizability of non-HDL lipoproteins and microalbuminuria in IDDM patients.

Zhang A, Vertommen J, Van Gaal L, De Leeuw I. Zhang A, et al. Diabetes Res Clin Pract. 1995 Sep;29(3):189-94. doi: 10.1016/0168-8227(95)01138-2. Diabetes Res Clin Pract. 1995. PMID: 8591712 Clinical Trial.

7

Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes.

Engelen W, Keenoy BM, Vertommen J, De Leeuw I. Engelen W, et al. Am J Clin Nutr. 2000 Nov;72(5):1142-9. doi: 10.1093/ajcn/72.5.1142. Am J Clin Nutr. 2000. PMID: 11063441 Clinical Trial.

8

Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome.

Manuel y Keenoy B, Moorkens G, Vertommen J, De Leeuw I. Manuel y Keenoy B, et al. Life Sci. 2001 Mar 16;68(17):2037-49. doi: 10.1016/s0024-3205(01)01001-3. Life Sci. 2001. PMID: 11388705

9

Effects of Atorvastatin on LDL sub-fractions and peroxidation in type 1 diabetic patients: a randomised double-blind placebo-controlled study.

Manuel-Y-Keenoy B, Van Campenhout C, Vertommen J, De Leeuw I. Manuel-Y-Keenoy B, et al. Diabetes Metab Res Rev. 2003 Nov-Dec;19(6):478-86. doi: 10.1002/dmrr.402. Diabetes Metab Res Rev. 2003. PMID: 14648807 Clinical Trial.

10

Impact of overweight on chronic microvascular complications in type 1 diabetic patients.

De Block CE, De Leeuw IH, Van Gaal LF. De Block CE, et al. Among authors: de leeuw ih. Diabetes Care. 2005 Jul;28(7):1649-55. doi: 10.2337/diacare.28.7.1649. Diabetes Care. 2005. PMID: 15983315

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters